Hydrocephalus
126
22
32
43
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
14 terminated out of 126 trials
75.4%
-11.1% vs benchmark
7%
9 trials in Phase 3/4
21%
9 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 43 completed trials
Clinical Trials (126)
Combined Flow and Pressure Study of Craniospinal Dynamic
Ultrasound (US) Guided External Ventricular Catheter Placement
Strategies for Weaning From External Ventricular Drainage
UVC in Prevention of Surgical Wound Infection
Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants
Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
European Study of Prodromal iNPH
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
Neurosurgical Outcome Network
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)
Improving Infant Hydrocephalus Outcomes in Uganda
MiDura-Study (Neuro-Patch in Duraplasty)
NIRS Monitoring in Premature Infants
Flow Detection in Open and Closed Shunt Valve Periods
Crystallization of LA and Adjuvant Mixtures in Cerebrospinal Fluid
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
CoMind Early Feasibility Study